1-12 of 12
Atsushi Suzuki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer

Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi, Kiyotaka Oshikawa, Noriyo Hayakawa, Mai Itoh, Chiyoko Nishime, Masami Suzuki, Aiko Nagayama, Yuko Kawai, Takako Hishiki, Tomomi Matsuura, Yoshiko Naito, Akiko Kubo, Arisa Yamamoto, Yujiro Yoshioka, Tomokazu Kurahori, Misa Nagasaka, Minako Takizawa, Naoharu Takano, Koji Kawakami, Michiie Sakamoto, Masatoshi Wakui, Takushi Yamamoto, Yuko Kitagawa, Yasuaki Kabe, Kenichi Horisawa, Atsushi Suzuki, Masaki Matsumoto, Makoto Suematsu
Journal: Cancer Research
Cancer Res (2024) 84 (7): 1065–1083.
https://doi.org/10.1158/0008-5472.CAN-23-2266
Published: 01 April 2024
View article titled, PRMT1 Sustains <em>De Novo</em> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
Open the PDF for PRMT1 Sustains <em>De Novo</em> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 5735: Novel KRAS G12D degrader ASP3082 demonstrates in vivo, dose-dependent KRAS degradation, KRAS pathway inhibition, and antitumor efficacy in multiple KRAS G12D-mutated cancer models

Takeyuki Nagashima, Tomohiro Yoshinari, Yoshihiro Nishizono, Mamoru Tasaki, Kohei Inamura, Hiroki Ishioka, Atsushi Suzuki, Fumio Osaki, Yosuke Yamanaka, Masahiko Hayakawa
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5735.
https://doi.org/10.1158/1538-7445.AM2023-5735
Published: 04 April 2023
View article titled, Abstract 5735: Novel KRAS G12D degrader ASP3082 demonstrates in vivo, dose-dependent KRAS degradation, KRAS pathway inhibition, and antitumor efficacy in multiple KRAS G12D-mutated cancer models
Journal Articles

Abstract 1788: A high-throughput chemical genetic screen reveals SALL4-induced metabolic vulnerabilities in cancer

Justin L. Tan, Feng Li, Joanna Z. Yeo, Kol Jia Yong, Mahmoud A. Bassal, Guo Hao Ng, May Yin Lee, Chung Yan Leong, Hong Kee Tan, Chan-Shuo Wu, Bee Hui Liu, Hon Man Chan, Zi Hui Tan, Yun Shen Chan, Siyu Wang, Zhi Han Lim, Tan Boon Toh, Lissa Hooi, Kia Ngee Low, Siming Ma, Nikki R. Kong, Alicia J. Stein, Yue Wu, Matan T. Thangavelu, Atsushi Suzuki, Giridharan Periyasamy, John M. Asara, Yock Young Dan, Glenn K. Bonney, Edward K. Chow, Guo-Dong Lu, Huck Hui Ng, Yoganathan Kanagasundaram, Siew Bee Ng, Wai Leong Tam, Li Chai, Daniel G. Tenen
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1788.
https://doi.org/10.1158/1538-7445.AM2020-1788
Published: 15 August 2020
View article titled, Abstract 1788: A high-throughput chemical genetic screen reveals SALL4-induced metabolic vulnerabilities in cancer
Journal Articles

Abstract 4029: Accumulation of arachidonic acid-containing phosphatidylinositol at the margin of colorectal cancer revealed by imaging mass spectrometry

Takanori Hiraide, Takanori Sakaguchi, Koji Ikegami, Yoshifumi Morita, Noritaka Masaki, Michihiko Waki, Eiji Sugiyama, Satoru Shinriki, Makoto Takeda, Yasushi Shibasaki, Shinichiro Miyazaki, Atsushi Suzuki, Hirotoshi Kikuchi, Mitsutoshi Setou, Hiroyuki Konno
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4029.
https://doi.org/10.1158/1538-7445.AM2015-4029
Published: 01 August 2015
View article titled, Abstract 4029: Accumulation of arachidonic acid-containing phosphatidylinositol at the margin of colorectal cancer revealed by imaging mass spectrometry
Journal Articles

Abstract 658: CBS9106 is a novel low toxic reversible oral CRM1 inhibitor with CRM1 degrading activity

Keiichi Sakakibara, Naoya Saito, Takuji Sato, Atsushi Suzuki, Yoko Hasegawa, Jonathan M. Friedman, Masashi Suganuma, Donald W. Kufe, Daniel D. VanHoff, Tadahiko Iwami, Takumi Kawabe
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 658.
https://doi.org/10.1158/1538-7445.AM2011-658
Published: 15 April 2011
View article titled, Abstract 658: CBS9106 is a novel low toxic reversible oral CRM1 inhibitor with CRM1 degrading activity
Journal Articles

Abstract #1824: A novel anti-cancer compound CBS9106 activates p53 and induces apoptosis in acute lymphoblastic leukemia and multiple myeloma cells

Keiichi Sakakibara, Naoya Saito, Takuji Sato, Atsushi Suzuki, Masashi Suganuma, Takumi Kawabe
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1824.
Published: 01 May 2009
View article titled, Abstract #1824: A novel anti-cancer compound CBS9106 activates p53 and induces apoptosis in acute lymphoblastic leukemia and multiple myeloma cells
Journal Articles

Comprehensive proteomic studies of epithelial ovarian cancers and development of a novel molecular tumor typing model

Atsuhiko Toyama, Takashi Shimada, Tetsuyoshi Sugita, Yutaka Aoki, Chikage Aoki, Yukari Umino, Atsushi Suzuki, Daisuke Aoki, Yataro Daigo, Yusuke Nakamura, Takaaki Sato
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3969.
Published: 01 May 2008
View article titled, Comprehensive proteomic studies of epithelial ovarian cancers and development of a novel molecular tumor typing model
Journal Articles

ARK5 regulates the growth of HTLV-1-infected T cells during glucose starvation

Mariko Tomita, Shuhei Taniguchi, Atsushi Suzuki, Tetsuro Nakazato, Chie Ishikawa, Taeko Okudaira, Hiroyasu Esumi, Naoki Mori
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 599.
Published: 01 May 2008
View article titled, ARK5 regulates the growth of HTLV-1-infected T cells during glucose starvation
Journal Articles

Comprehensive proteomic studies on ovarian cancer and biomarker discovery for molecular tumor typing

Atsuhiko Toyama, Takashi Shimada, Tetsuyoshi Sugita, Yutaka Aoki, Chikage Aoki, Yukari Umino, Atsushi Suzuki, Daisuke Aoki, Yataro Daigo, Yusuke Nakamura, Takaaki Sato
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 604.
Published: 01 May 2007
View article titled, Comprehensive proteomic studies on ovarian cancer and biomarker discovery for molecular tumor typing
Journal Articles

Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human

Naoki Morito, Keigyou Yoh, Yuki Fujioka, Takako Nakano, Homare Shimohata, Yuko Hashimoto, Akiko Yamada, Atsuko Maeda, Fumihiko Matsuno, Hiroyuki Hata, Atsushi Suzuki, Shigehiko Imagawa, Hiroaki Mitsuya, Hiroyasu Esumi, Akio Koyama, Masayuki Yamamoto, Naoyoshi Mori, Satoru Takahashi
Journal: Cancer Research
Cancer Res (2006) 66 (2): 812–819.
https://doi.org/10.1158/0008-5472.CAN-05-2154
Published: 19 January 2006
View article titled, Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human
Open the PDF for Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human in another window
Journal Articles

Sialidase expressed from cancer cells can affect the formation of peritoneal dissemination of ovarian cancer

Hiroyuki Nomura, Daisuke Aoki, Yutaka Tamada, Atsushi Suzuki, Nao Suzuki, Nobuyuki Susumu, Shiro Nozawa
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1318.
Published: 01 May 2005
View article titled, Sialidase expressed from cancer cells can affect the formation of peritoneal dissemination of ovarian cancer
Journal Articles

Sialyl Lewis X-dependent Lung Colonization of B16 Melanoma Cells through a Selectin-like Endothelial Receptor Distinct from E- or P-Selectin

Jianing Zhang, Jun Nakayama, Chikara Ohyama, Masami Suzuki, Atsushi Suzuki, Minoru Fukuda, Michiko N. Fukuda
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4194–4198.
Published: 01 August 2002
View article titled, Sialyl Lewis X-dependent Lung Colonization of B16 Melanoma Cells through a Selectin-like Endothelial Receptor Distinct from E- or P-Selectin
Open the PDF for Sialyl Lewis X-dependent Lung Colonization of B16 Melanoma Cells through a Selectin-like Endothelial Receptor Distinct from E- or P-Selectin in another window